Schedule & Agenda

World-class education program, delivered digitally.

Search General Info
Search Education
Search Partnering Companies

Explore the BIO Digital 2021 Sessions below.

BIO Digital
Date
  • Show All
Time
  • Show All
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Digital
Jump to Day
14 Results
On Demand
3 clinical stage assets: AMO-02 in Phase III in Myotonic Dystrophy AMO-01 in Phelan McDermid…
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders…
Annovis Bio, Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as…
Ascent Innovation is a new generation digital therapeutic technology developer founded by a group…
Emerald Health Pharmaceuticals (EHP) is a private clinical-stage biotech company with a portfolio…
Gismo Therapeutics Inc. is a preclinical-stage biopharmaceutical company targeting fundamental…
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of…
NeuroScientific Biopharmaceuticals Ltd is an Australian public listed company (ASX:NSB) focused on…
Neurotez wants to overcome Alzheimer’s disease once and for all. Our novel approach focuses on…
Oligomerix has a clear and de-risked line-of-sight into the clinic with its lead tau inhibitor of…
Receptor Life Sciences is a pharmaceutical company that applies FDA-approved drug-delivery…
In February 2021 Jazz Pharmaceuticals entered into an agreement to purchase GW Pharma for $7.2B…
Unlearn is using novel AI approaches to create disease progression models for clinical research. By…
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and…